Albeit anthracyclines are widely used in the treatment of solid tumors and leukemias, their mechanism of action has not been elucidated. The present study gives relevant information about the role of nonlamellar membrane structures in signaling pathways, which could explain how anthracyclines can exert their cytocidal action without entering the cell [Tritton, T. R. & Yee, G. (1982) Science 217,[248][249][250]. The anthracycline daunomycin reduced the formation of the nonlamellar hexagonal (Hn) phase (i.e., the hexagonal phase propensity), stabilizing the bilayer structure of the plasma membrane by a direct interaction with membrane phospholipids. As a consequence, various cellular events involved in signal transduction, such as membrane fusion and membrane association of peripheral proteins [e.g., guanine nucleotide-binding regulatory proteins (G proteins and protein kinase C-a*3)], where nonlamellar structures (negative intrinsic monolayer curvature strain) are required, were altered by the presence of daunomycin. Functionally, daunomycin also impaired the expression of the high-affinity state of a G protein-coupled receptor (ternary complex for the a2-adrenergic receptor) due to G-protein dissociation from the plasma membrane. In vivo, daunomycin also decreased the levels of membrane-associated G proteins and protein kinase C-a.3 in the heart. The occurrence of such nonlamellar structures favors the association of these peripheral proteins with the plasma membrane and prevents daunomycin-induced dissociation. These results reveal an important role of the lipid component of the cell membrane in signal transduction and its alteration by anthracyclines.
Anthracyclines are potent antitumor drugs. They bind with high affinity to DNA (1) , causing a stabilization of the DNA double helix (2) . Although a mechanism of anthracycline cytotoxicity based on their interaction with DNA has been proposed, strong evidence has accumulated suggesting the involvement of the plasma membrane in the cytotoxic action of these antitumor drugs. The plasma membrane is the first cellular target found by anthracyclines, and it is able to bind a large number of drug molecules (3, 4) , so that a primary action on the physicochemical properties of the cell membrane could trigger a series of events responsible for their cytotoxic effect (5) . Anthracyclines with little or no ability to bind to DNA, such as N-trifluoroacetyladriamycin 14-valerate (AD 32) , exhibit a good antitumor activity, which argues against DNAmediated effects (6) . A number of physicochemical properties of the plasma membrane are affected by anthracyclines (3, 5, 7) , and agarose-linked doxorubicin (former generic name, adriamycin) is able to kill cells, without penetrating them, solely by its interaction with the plasma membrane (8) . Despite all these indications that the antitumor activity of anthracyclines originates from their interaction with cellular membranes, the mechanism of cytotoxicity has not been elucidated. Here we present evidence that nonlamellar membrane structures are involved in the transduction of signals, favoring the interaction of peripheral proteins involved in signaling pathways [e.g., guanine nucleotide-binding regulatory proteins (G proteins) and protein kinase C (PKC) isoforms a and 13], and show how the anthracycline daunomycin (DNM) alters the structure and function of biological and model membranes.
DNM inhibited the hexagonal (HI,) phase propensity, which is required for events related to the lipid (9-11) and protein (11) (12) (13) components of the plasma membrane involved in signal transduction. These data suggest a plausible mechanism of cytotoxicity for anthracyclines.
MATERIALS AND METHODS

Differential Scanning Calorimetry (DSC). The experiments
were performed similarly to those described previously (7) . In brief, 1-palmitoyl-2-oleoyl phosphatidylethanolamine (POPE) or dipalmitoyl phosphatidylcholine (DPPC) (Avanti Polar Lipids) without or with DNM (Sigma) was dissolved in chloroform on the day of the experiment and mixed at the appropriate drug/lipid ratios. The solvent was removed under argon flux and the residue was submitted to vacuum for at least 3 hr. The lipid film was resuspended in 10 mM Hepes/100 mM NaCl/1 mM EDTA at pH 7.4 by vortex shaking for 2 min at 35°C and degassed prior to use. The phospholipid concentration was always 1 mM. DSC experiments were performed in a Microcal MC-2 microcalorimeter (Amherst, MA) at a scan rate of 0.5 K/min. Thermograms of POPE and DPPC were analyzed with the program ORIGIN (Microcal).
Vesicle Aggregation/Fusion Assays. Egg phosphatidylcholine (PC) was dissolved in chloroform/methanol (2:1, vol/vol) in the absence or presence of DNM. The solvent was removed by evaporation under argon followed by vacuum for at least 3 hr. The lipid film was suspended in 10 mM Hepes/100 mM NaCl at pH 7.4 by vortex shaking. Unilamellar liposomes were prepared by sonication of the lipid dispersion with a Branson tip sonicator until the suspension cleared. Metal particles from the sonicator tip, as well as multilamellar liposomes, were removed from the preparation by centrifugation at 100,000 x g for 30 min. This suspension was subjected to two freeze-thaw cycles. The increase in OD600 (wavelength at which DNM has no absorption or emission), produced by vesicle aggregation/ fusion, was monitored in a Zeiss DMR11 spectrophotometer using a 5-cm-pathlength cuvette. The reference cuvette contained 5 ml of 1 phosphatidylethanolamine; PKC, protein kinase C; POPE, 1-palmitoyl-2-oleoyl phosphatidylethanolamine. *To whom reprint requests should be addressed.
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above and the sample cuvette contained liposomes without or with 50 ,M DNM. The assay started with the addition of 50 ,ul of 10 mM Hepes/100 mM NaCl at pH 7.4 without (reference cuvette) or with (sample cuvette) CaCl2 (the final concentration of Ca2+ was 10 mM) and the increase in absorbance at 600 nm was monitored for 400 s. Experimental data were analyzed with a program for nonlinear fitting to mono-and multiexponential curves (14) . No significant improvement of the statistical parameters was found for curves with three or more exponential terms, so that a biexponential (two-step) equation was enough to explain the Ca2+-induced aggregation/fusion of liposomes:
AT=Ao +Ale-t/Tl +A2e-t/T2 [1] whereAT is the amplitude of the overall process, A1 and 1 are the amplitude and lifetime of the fast process, and A2 and T2 are the amplitude and lifetime of the slow process.
SDS/PAGE, Immunoblotting, and Antisera. One male rat (Sprague-Dawley, 250-300 g) brain cortex was homogenized in an Ultraturrax homogenizer (Janke & Kunkel, Germany) in 20 volumes (vol/wt) of 50 mM Tris HCl/1 mM EDTA/2 mM MgCl2/1 mM phenylmethylsulfonyl fluoride/5 mM iodoacetamide at pH 7.5. The membrane suspension was divided into two 5-ml aliquots with or without 1 mM DNM. After a 30-min incubation with rotation at 4°C, the membrane suspensions were centrifuged at 800 x g for 10 min at 4°C. Pellets (nuclei and whole cells) were discarded and the supernatants were centrifuged twice at 40,000 x g for 10 min at 4°C. The brain membrane pellets were resuspended in the above buffer to yield a protein content of 2-4 mg/ml. Next, 15 ,ul of tissue suspension was mixed with an equal volume of 40 mM Tris-HCl/2% SDS at pH 6.8 and incubated at 75°C for 5 min.
After cooling, 20 [lI of N-ethylmaleimide was added and the samples were incubated for 15 min at room temperature. Electrophoresis loading buffer (25 ,ul of 100 mM Tris-HCl/5% SDS/30% glycerol/0.01% bromphenol blue at pH 6.8) was added to the mixtures, which were then boiled for 3 min in preparation for SDS/PAGE followed by immunoblot analysis using 1:5000 dilutions for the primary and secondary antibodies. The immunoreactivity of proteins (G-protein subunits, PKC-a and -3, and a-tubulin) was detected by a chemiluminescence procedure (Amersham) (15) .
In another series of experiments, cortical membranes were enriched in DPPC or POPE by incubation for 1 hr with either phospholipid before the addition of buffer or 1 mM DNM. The initial concentration of membrane phospholipids was 5-6 mM [2.5-3 mM PC and 0.9-1.2 mM phosphatidylethanolamine (PE)] and the concentration of DPPC or POPE added was always 5 mM. Liposomes were induced to fuse with the plasma membrane by addition of 20 mM CaCl2 to the homogenization buffer. Then, the membranes were centrifuged at 40,000 x g for 15 min at 4°C, resuspended in Ca2+-free homogenization buffer, and proccesed as described above. In some experiments, rats were treated with DNM (10 mg/kg, i.p., for 48 hr) to assess in vivo the effects of the anthracycline on G-protein subunits and PKC-a and -,B. Antisera against specific Gprotein subunits (AS/7, ail/2; GC/2, a0; RM/1, a,; SW/i, 13) were purchased from DuPont/NEN (Bad Homburg, Germany), monoclonal anti-PKC (clone MC 5) antibody was from Amersham, and monoclonal anti-a-tubulin antibody was from Sigma.
Radioligand Binding Assays. Rat cortical membranes (P2 fractions) were obtained as described (16) . The binding of the a2-adrenergic receptor (a2 AR) antagonist [3H]RX821002 (2-methoxyidazoxan; Amersham) (1 nM) was measured in 1.1-ml aliquots (50 mM Tris-HCl/0.1% ascorbic acid, pH 7.5) of the cortical membranes, which were incubated with shaking for 30 min at 25°C in the absence or presence of various concentrations of the competing agonist drug (-)-epinephrine (33 pM to 1 mM, 22 concentrations). Assay buffer also included 0.3 ,uM 5-hydroxytryptamine (5-HT) to prevent the binding of [3H]RX821002 to 5-HT1A receptors (17) . The binding of [3H]idazoxan (Amersham) (4 nM) to I2 imidazoline receptors was measured as above but in the presence of 1 ,uM (-)-epinephrine, to prevent binding to a2ARs (16) , and in the absence or presence of various concentrations of the competing drug cirazoline (33 pM to 1 mM, 22 concentrations). Total binding was determined and plotted as a function of the drug concentration. In some competition studies, cortical membranes were also incubated in the presence of 0.1 mM guanosine 5'-[P3,y-imido]triphosphate (GTP[13,y-NH]) (a nonhydrolyzable GTP analog), 140 mM NaCl, and 1 mM EDTA in order to eliminate the high-affinity state of the a2AR for agonists (18) . Receptor-bound radioligand was measured as described (16) . Analyses of competition experiments (Ki, inhibition constant; Bma,,, density of binding sites), as well as the fitting of data to the appropriate binding model, were performed by computer-assisted nonlinear regression using the EBDA-LIGAND programs (16, 19, 20) .
RESULTS AND DISCUSSION
Effect of DNM on the Thermotropic Behavior of Model Membranes. A series of experiments using model synthetic membranes of POPE showed that DNM caused a stabilization of the lamellar (bilayer) structure, impairing or avoiding in a concentration-dependent manner the formation of hexagonal HI, (nonlamellar) structures. DSC thermograms of POPE in the absence of DNM (Fig. 1A) 
. In the presence of DNM, the increase in TH was associated with the transition (Fig. 1B) and the decrease in the transition enthalpy (Fig. 1C) indicated that the drug stabilized the bilayer structure of POPE and eventually avoided the formation of HI, structures. Conversely, DNM did not alter the L13-to-La (i.e., solid-to-liquid crystalline) phase transition of POPE (Fig. IA) and that of DPPC; a bilayer-forming phospholipid (data not shown). PEs promote the in vivo occurrence of the hexagonal (HI,) phase, which is the most abundant nonlamellar structure (9, 21) and which has been associated with physiological cellular events such as the activity of a number of enzymes and other membrane proteins, the fusion of membranes (necessary inter alia for receptor-mediated endocytosis, membrane receptors sequestration, and release of neurotransmitters), and the cytoplasm-to-membrane translocation of peripheral membrane-associated proteins (9-11, 21, 22) . The lipid-lipid interactions are of structural and functional significance for the lipid-protein interactions and the activity of membrane proteins (23); in fact, the activity of PKC is modulated by agents that alter the lamellar-to-hexagonal phase transition (10, 24) and depends on its association with the plasma membrane (25) . On the other hand, G proteins are hydrophilic and can be found in the cytosol or associated with membranes (26) . Therefore, it appears that the cytosol-membrane cycle, which could be regulated by the plasma membrane lipid composition and structure, is crucial for the biological role of G proteins and PKC. For these reasons, the alterations produced by DNM on events regulated by the occurrence of hexagonal phases (e.g., the vesicle aggregation/fusion process in model membranes and the peripheral protein-membrane interactions in biological membranes) were investigated next.
DNM-Induced Alterations of the Lipid-Lipid and LipidProtein Interactions. The membrane fusion kinetics was studied with liposomes of egg PC, which undergo fusion in the presence of Ca2+. The aggregation/fusion of PC vesicles was found to fit a two-step mechanism ( Fig. 2A) , as described previously (14) . The presence of 50 ,uM DNM (a concentration causing only partial depletion of the lamellar-to-hexagonal phase transition of POPE; see Fig. 1 ) altered the aggregation/ fusion kinetics of PC vesicles; i.e., the lifetime of both reaction steps (Ti and T2, respectively) was markedly increased, and the overall amplitude of the process (AT) was decreased by 50% ( Fig. 2A) , indicating that DNM caused a reduction in both the rate and the extent of the vesicle aggregation/fusion process. This result was consistent with the DSC data, because nonlamellar structures are involved in the fusion of bilayers.
On the other hand, DNM also caused a severe reduction in the cell membrane content of several peripheral membraneassociated proteins, e.g. various G-protein a and 3 subunits and PKC-af3 (Fig. 2B) . The decrease in membrane-associated G proteins and PKC-af3 levels was not due to protein degradation, since the total cellular content of these proteins remained unchanged after treatment with DNM (data not shown). These proteins are crucial in cellular signaling pathways (28, 29) , and their activity depends on their association with the plasma membrane. Conversely, in experiments using rat brain membranes enriched in POPE, which favors the negative intrinsic monolayer curvature strain (nonlamellar or hexagonal phase propensity), the content of G proteins and PKC-ac3 was increased (42% and 66%, respectively) with respect to that observed in membranes enriched in dimyristoyl phosphatidylcholine (DMPC, a bilayer-forming phospholipid) (Fig. 3) . Moreover (24) . This mechanism could also account for the alteration of PKC activity induced by DNM in cultured cells (12) . It has been pointed out that polar/apolar compounds (e.g., DNM) activate PKC at low concentrations and inhibit its activity at higher concentrations (30) , possibly by altering the occurrence of nonlamellar structures. The physiological relevance of the proposed mechanisms is supported by the marked decreases in the levels of membrane-associated G proteins and PKC-ci3 (22% to 26%, P < 0.005), but not of a-tubulin, observed in the heart of rats (a well-known in vivo target for anthracycline drugs) treated with a single dose of DNM (10 mg/kg, i.p., for 48 hr) (Fig. 4) .
DNM-Induced Functional Alterations ofG Protein-Coupled
Receptors. Next we studied how the loss of membraneassociated G proteins affected the function of the ubiquitous G protein-coupled receptors (e.g., a2ARs coupled preferentially to Gi proteins, which mediate inhibition of adenylyl cyclase) (31) . For these and other G protein-coupled receptors, agonist binding to the receptor promotes the formation of a ternary complex composed of the agonist, the receptor, and a G protein, which is called the receptor high-affinity state, while the low-affinity state is characterized by the absence of G-protein coupling and signal transduction (32) (33) (34) (35) and adenylyl cyclase activity (13) , abnormal expression and activity of PKC in cultured cells (12, 36) , as well as the activity of other membrane proteins which do not bind anthracyclines (37) , and the induction of differentiation of TS12 and SK-N-MC human neuroblastoma cells at subtoxic doses of anthracyclines (38) . Moreover, this latter study (38) suggested a possible action of these drugs on the cell cycle and the signaling pathways, which has been documented with the present experiments. The present data are also in agreement with the suggested role of membrane lipids in the expression of newly synthesized membrane elements (39) . Evidence 
